 MENLO PARK, Calif., March 02, 2021 GLOBE NEWSWIRE -- Pacific Biosciences of California, Inc. NASDAQ: PACB Pacific Biosciences or the Company, a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced that the Companys Board of Directors granted non-qualified stock options covering an aggregate of 80,000 shares of Pacific Biosciences common stock and restricted stock units RSUs covering 40,000 shares of Pacific Biosciences common stock to a recently hired employee under the Pacific Biosciences 2020 Inducement Equity Incentive Plan the 2020 Inducement Plan effective on February 25, 2021. 